Fulcrum Therapeutics Stock (NASDAQ: FULC) stock price, news, charts, stock research, profile.
Open | $3.40 |
Close | - |
Volume / Avg. | 695.94K / 1.69M |
Day Range | $3.17 - $3.42 |
52 Wk Range | 2.87 - 13.70 |
Market Cap | $202.80M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 23 |
Short Interest | 16.08% |
Days to Cover | 10.61 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Fulcrum Therapeutics (NASDAQ:FULC) through any online brokerage.
Other companies in Fulcrum Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS), Esperion Therapeutics (NASDAQ:ESPR) and Telomir Pharmaceuticals (NASDAQ:TELO).
Fulcrum Therapeutics has a consensus price target of $7.50.
The stock price for Fulcrum Therapeutics (NASDAQ: FULC) is $3.25 last updated September 23, 2024 at 1:43 PM EDT.
There are no upcoming dividends for Fulcrum Therapeutics.
Fulcrum Therapeutics’s Q3 earnings are confirmed for Tuesday, November 5, 2024.
There is no upcoming split for Fulcrum Therapeutics.
Fulcrum Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.